Stocks / NASDAQ / Cara Therapeutics, Inc.

Cara Therapeutics, Inc.

Our Opinion

Cara Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Supporting Evidence:

CARA THERAPEUTICS, INC. Annual report  2013

The following report cites that the company’s product CR845 has been tested on animals. “In pharmacokinetic studies, animals administered analgesic and supra-analgesic doses of CR845 exhibited no measurable concentrations of drug in extracted brain tissue indicating that the CNS was not the site of action for CR845.” (Page 16)

Company Description

CARA Therapeutics, Inc. is a clinical-stage company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT. [Source: MarketWatch]

Company Website: